SCHEMBL18376242

SCHEMBL18376242

CN1CCN(c2cccc(Nc3ncc4cccc(-c5ccc(N(C)C)cc5)c4n3)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 12/20 0.56
▸ BRD4 O60885 3/20 0.56
▸ JAK3 P52333 7/20 0.55
▸ PTK2 Q05397 7/20 0.55
▸ JAK1 P23458 2/20 0.51
▸ FGFR1 P11362 1/20 0.51
▸ KDR P35968 1/20 0.51
▸ ABCB1 P08183 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ EGFR P00533 1/20 0.48
▸ CCNT1 O60563 2/20 0.47
▸ CCNA2 P20248 2/20 0.47
▸ CDK2 P24941 2/20 0.47
▸ CDK9 P50750 2/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ FGFR2 P21802 1/20 0.46
▸ TTK P33981 2/20 0.46
▸ CDK1 P06493 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ CDK7 P50613 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29371785 1.00 JAK2 (0.56) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376235 0.90 JAK2 (0.54) JAK2BRD4JAK3PTK2JAK1
SCHEMBL29370808 0.90 JAK2 (0.54) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376225 0.89 JAK2 (0.59) JAK2BRD4JAK3PTK2JAK1
SCHEMBL29371805 0.89 JAK2 (0.58) JAK2BRD4JAK3PTK2JAK1
SCHEMBL29371867 0.89 JAK2 (0.60) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376589 0.89 JAK2 (0.58) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376722 0.89 JAK2 (0.60) JAK2BRD4JAK3PTK2JAK1
SCHEMBL30859687 0.87 JAK2 (0.57) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376740 0.87 JAK2 (0.57) JAK2BRD4JAK3PTK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN disclosed
Send feedback